$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

COMPLEMENT FACTOR P IN CHOROIDAL NEOVASCULAR MEMBRANES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION

Retina, v.29 no.7, 2009년, pp.966 - 973  

WOLF-SCHNURRBUSCH, UTE E. K. (From the *Department of Ophthalmology, Inselspital, and †Department of Pathology, School of Medicine, University of Bern, Bern, Switzerland.) ,  STUCK, ANNA K. ,  HESS, ROBERTO ,  WOLF, SEBASTIAN ,  ENZMANN, VOLKER

Abstract

PURPOSE:: To evaluate whether complement Factor P (properdin) was present in surgically removed choroidal neovascular membranes of patients with age-related macular degeneration (AMD) and to investigate whether associated pre- and postoperative clinical characteristics can be correlated. METHODS:: The study population consisted of 26 AMD patients (26 eyes) with the exclusion criterion of prior treatment of the choroidal neovascular membranes. Factor P was detected immunocytochemically on paraffin sections (7 μm) by a polyclonal rabbit antihuman antibody. RESULTS:: Eleven of 22 assessable membranes showed a positive reaction for Factor P. The average percentage of Factor P-positive cells per membrane ranged from 0.65% to 4.09%. The duration of visual loss was significantly longer (8.6 ± 2.7 vs. 3.9 ± 0.8 months), and the size of postoperative measured area of atrophic retinal pigment epithelium was larger (27.6 ± 7.6 vs. 15.0 ± 6.9 mm) in patients with Factor P-positive membranes compared with Factor P-negative ones. CONCLUSION:: Factor P was expressed in 50% of choroidal neovascular membranes of patients with AMD. The group with Factor P-positive membranes differed significantly from the Factor P-negative group in key clinical outcomes. Additional studies need to investigate the role of Factor P in the development of AMD for potential therapeutic intervention.

참고문헌 (31)

  1. Surv Ophthalmol Donoso 51 137 2006 10.1016/j.survophthal.2005.12.001 The role of inflammation in the pathogenesis of age-related macular degeneration. 

  2. Arch Ophthalmol DeAngelis 125 49 2007 10.1001/archopht.125.1.49 Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. 

  3. Prog Ret Res Penfold 20 385 2001 10.1016/S1350-9462(00)00025-2 Immunological and aetiological aspects of macular degeneration. 

  4. Arch Ophthalmol Zarbin 122 598 2004 10.1001/archopht.122.4.598 Current concepts in the pathogenesis of age-related macular degeneration. 

  5. Am J Ophthalmol Nussenblatt 144 618 2007 10.1016/j.ajo.2007.06.025 Age-related macular degeneration and the immune response: implications for therapy. 

  6. Curr Opin Genet Dev DeWan 17 228 2007 10.1016/j.gde.2007.04.004 Two genetic pathways for age-related macular degeneration. 

  7. JAMA Despriet 296 301 2006 10.1001/jama.296.3.301 Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. 

  8. Science Klein 308 385 2005 10.1126/science.1109557 Complement factor H polymorphism in age-related macular degeneration. 

  9. Invest Ophthalmol Vis Sci Sepp 47 536 2006 10.1167/iovs.05-1143 Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. 

  10. Science Haines 308 419 2005 10.1126/science.1110359 Complement factor H variant increases the risk of age-related macular degeneration. 

  11. Proc Natl Acad Sci USA Hageman 102 7227 2005 10.1073/pnas.0501536102 A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. 

  12. Science Edwards 308 421 2005 10.1126/science.1110189 Complement factor H polymorphism and age-related macular degeneration. 

  13. Nat Genet Gold 38 458 2006 10.1038/ng1750 Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. 

  14. Ann NY Acad Sci Colten 332 482 1979 10.1111/j.1749-6632.1979.tb47142.x Synthesis and secretion of complement proteins by macrophages. 

  15. J Biol Chem Hourcade 81 2128 2006 10.1074/jbc.M508928200 The role of properdin in the assembly of the alternative pathway C3 convertases of complement. 

  16. Ophthalmology Thomas 99 952 1992 10.1016/S0161-6420(92)31888-3 Surgical management of subfoveal choroidal neovascularization. 

  17. Am J Ophthalmol Lambert 113 257 1992 10.1016/S0002-9394(14)71576-4 Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. 

  18. Retina Green 11 328 1991 10.1097/00006982-199111030-00010 Clinicopathologic studies of treated choroidal neovascular membranes. A review and report of two cases. 

  19. Trans Am Ophthalmol Soc Green 75 180 1977 Senile macular degeneration: a histopathologic study. 

  20. Arch Ophthalmol 109 1220 1991 10.1001/archopht.1991.01080090044025 Laser photocoagulation of subfoveal neovascular lesions in AMD. Results of a randomized clinical trial. 

  21. Ophthalmology Grossniklaus 101 1099 1994 10.1016/S0161-6420(13)31216-0 Clinicopathologic features of surgically excised choroidal neovascular membranes. 

  22. Arterioscler Thromb Vasc Biol Nagai 26 2252 2006 10.1161/01.ATV.0000240050.15321.fe Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. 

  23. Proc Natl Acad Sci USA Kemper 105 9023 2008 10.1073/pnas.0801015105 The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. 

  24. Proc Natl Acad Sci USA Johnson 103 17456 2006 10.1073/pnas.0606234103 Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. 

  25. Ann Med Gehrs 38 450 2006 10.1080/07853890600946724 Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. 

  26. Exp Eye Res Johnson 70 441 2000 10.1006/exer.1999.0798 A potential role for immune complex pathogenesis in drusen formation. 

  27. J Immunol Thurman 176 1305 2008 10.4049/jimmunol.176.3.1305 The central role of the alternative complement pathway in human disease. 

  28. Mol Immunol Minta 25 1363 1988 10.1016/0161-5890(88)90052-1 Biosynthesis of complement factor P (properdin) by the human pre-monocyte cell line (U-937). 

  29. J Immunol Bora 174 491 2005 10.4049/jimmunol.174.1.491 Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. 

  30. Surv Ophthalmol Zayit-Soudry 52 227 2007 10.1016/j.survophthal.2007.02.008 Retinal pigment epithelial detachment. 

  31. Br J Ophthalmol Kanda 92 448 2008 10.1136/bjo.2007.131581 Inflammation in the pathogenesis of age-related macular degeneration. 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로